Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production
- PMID: 9515807
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production
Abstract
Tumor-derived prostaglandin E2 (PGE2) modifies cytokine balance and inhibits host immunity. We hypothesized that a high level of PGE2 production by lung tumor cells is dependent on tumor cyclooxygenase (COX)-2 expression. We found that PGE2 production by A549 non-small cell lung cancer (NSCLC) cells was elevated up to 50-fold in response to interleukin (IL)-1beta. Reversal of IL-1beta-induced PGE2 production in A549 cells was achieved by specific pharmacological or antisense oligonucleotide inhibition of COX-2 activity or expression. In contrast, specific COX-1 inhibition was not effective. Consistent with these findings, IL-1beta induced COX-2 mRNA expression and protein production in A549 cells. Specific inhibition of COX-2 abrogated the capacity of IL-1beta-stimulated A549 cells to induce IL-10 in lymphocytes and macrophages. Furthermore, specific inhibition of A549 COX-2 reversed the tumor-derived PGE2-dependent inhibition of macrophage IL-12 production when whole blood was cultured in tumor supernatants. Our results indicate that lung tumor-derived PGE2 plays a pivotal role in promoting lymphocyte and macrophage IL-10 induction while simultaneously inhibiting macrophage IL-12 production. Immunohistochemistry of human NSCLC tissues obtained from lung cancer resection specimens revealed cytoplasmic staining for COX-2 within tumor cells. This is the first description of functional COX-2 expression by NSCLC cells and the definition of a pathway whereby tumor COX-2 expression and a high level of PGE2 production mediate profound alteration in cytokine balance in the lung cancer microenvironment.
Similar articles
-
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.Cancer Res. 2003 Feb 15;63(4):766-70. Cancer Res. 2003. PMID: 12591723
-
Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.J Immunol. 1998 Sep 1;161(5):2441-8. J Immunol. 1998. PMID: 9725242
-
Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.Pain. 2005 Jan;113(1-2):113-22. doi: 10.1016/j.pain.2004.09.031. Pain. 2005. PMID: 15621371
-
Molecular pathology of cyclooxygenase-2 in neoplasia.Ann Clin Lab Sci. 2000 Jan;30(1):3-21. Ann Clin Lab Sci. 2000. PMID: 10678579 Review.
-
Cyclooxygenase-2 inhibitors in lung cancer.Clin Lung Cancer. 2004 Jan;5(4):245-53. doi: 10.3816/CLC.2004.n.006. Clin Lung Cancer. 2004. PMID: 14967078 Review.
Cited by
-
Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.Pathol Oncol Res. 2015 Sep;21(4):1123-31. doi: 10.1007/s12253-015-9940-9. Epub 2015 May 13. Pathol Oncol Res. 2015. PMID: 25962348
-
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.J Exp Med. 2005 Oct 3;202(7):931-9. doi: 10.1084/jem.20050715. Epub 2005 Sep 26. J Exp Med. 2005. PMID: 16186186 Free PMC article.
-
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?Drugs. 2007;67(6):821-45. doi: 10.2165/00003495-200767060-00001. Drugs. 2007. PMID: 17428102 Review.
-
National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms.Neoplasia. 2002 Mar-Apr;4(2):91-7. doi: 10.1038/sj.neo.7900226. Neoplasia. 2002. PMID: 11896563 Free PMC article.
-
Smoking and lung cancer: the role of inflammation.Proc Am Thorac Soc. 2008 Dec 1;5(8):811-5. doi: 10.1513/pats.200809-100TH. Proc Am Thorac Soc. 2008. PMID: 19017734 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials